Don’t miss the latest developments in business and finance.

RPG Life Sciences gains after announcing foray into cosmetic industry

Image
Capital Market
Last Updated : Jun 28 2016 | 1:28 PM IST

RPG Life Sciences rose 4.51% to Rs 243.55 at 12:32 IST on BSE after the company announced its foray into cosmetology, one of India's fastest growing markets.

The announcement was made during market hours today, 28 June 2016.

Meanwhile, the S&P BSE Sensex was up 99.18 points, or 0.38%, to 26,502.14

On BSE, so far 70,000 shares were traded in the counter as against an average daily volume of 16,901 shares in the past one quarter. The stock hit a high of Rs 251.90 and a low of Rs 230 so far during the day. The stock had hit a record high of Rs 360.60 on 3 December 2015. The stock had hit a 52-week low of Rs 138 on 24 August 2015. The stock had underperformed the market over the past 30 days till 27 June 2016, falling 11.97% compared with 0.94% fall in the Sensex. The scrip, however, outperformed the market in past one quarter, advancing 7.15% as against Sensex's 6.03% rise.

The small-cap company has an equity capital of Rs 13.23 crore. Face value per share is Rs 8.

RPG Life Sciences has entered into a technical collaboration with Italian cosmetic leader Labo Cospropher. The company is in-licensing two research -based products to be launched in the Indian cosmetic market this July, RPG Life Sciences said. A separate division has been created to market these unique products titled Crescina and Fillerina, specializing in hair-fall and anti-aging, respectively, the company said. Crescina is a research-based global product designed for hair-regrowth with nine patents worldwide. Fillerina is another breakthrough product designed for anti-aging treatment with Swiss patent.

RPG Life Sciences' net profit dropped 52.13% to Rs 2.25 crore on 5.32% rise in total income to Rs 70.31 crore in Q4 March 2016 over Q4 March 2015.

More From This Section

RPG Life Sciences is an integrated pharmaceutical company operating in the domestic and international markets in the Branded Formulations, Global Generics, Synthetic and Fermentation APIs space. The company is a research-based pharmaceutical company producing a wide range of medicines.

Powered by Capital Market - Live News

Also Read

First Published: Jun 28 2016 | 12:42 PM IST

Next Story